Replies to post #404895 on NorthWest Biotherapeutics Inc (NWBO)

[Basin Street Blues]

rubbish , always cash transactions unless unavoidable

[sukus]

I believe there are plenty Big Pharmas with greater than 150 to 200 Billion market capitalization that can still very much afford to buy the 25 to 30 Billion company by issuing shares.

[BWIS]

is 40% what you Brits pay on CG?

although that sounds really high, if you're in the top tax bracket in US Short Term CG is and has been that high in the US. top bracket Currently like 400k i believe. which goes quick for people who make good money and then make a Short term cap gain.

point is, although that's pretty high, that's what our top federal rate is on ordinary income.

but we just keep cutting taxes and increasing spending every few years. a great plan as long as you keep paying your creditors i guess.

[anders2211]

that's, not the point BSB is making they could be paying in bitcoin, gold, dogfood for LG's new poodles or noodles for PM. The point is that, if indeed Merck is the suiter, Merck will not want to spend a huge amount or x2 for that matter for a risky take over in the cancer treatment industry within a short/mid-term period of time.

Another sobering thought is that if Merck has/had Northwest on its radar all this time then Merck does NOT see DCVAX platform as the treatment for all solid tumors as many say it is. Otherwise, why acquire Acceleron? The DCVAX platform has all the answers right so why Acceleron?
I have always said that if LP would have focussed on NWBO and DCVAX then she would have initiated Direct, now then NWBO could have counted on many suiters. But she chooses more important projects such as Cognate, Advent, an Alzheimer biotech etc.

I personally do not see an NWBO buy-out until after L is approved.